Form4insider filings, from the source

SEC Form 4 · accession 0000899243-17-009893

Global Blood Therapeutics, Inc. · GBT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Apr 6, 2017
Accepted (ET)
Apr 10, 2017 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Apr 6, 2017S31,225$33.229D229,773D
Common StockF2holding———4,475,191ISee Footnote
Common StockF3holding———285,713ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses